IGR Ophthalmic Drugs Market | Page 5

4.4. Retinal Disorder 5. Global Ophthalmic Drugs Market by Dispense Type 5.1. Prescription 5.2. Over the Counter 6. Global Ophthalmic Drugs Market by Region 2017-2023 6.1. North America 6.1.1. North America Ophthalmic Drugs Market by Disease Condition 6.1.2. North America Ophthalmic Drugs Market by Dispense Type 6.1.3. North America Ophthalmic Drugs Market by Country 6.2. Europe 6.2.1. Europe Ophthalmic Drugs Market by Disease Condition 6.2.2. Europe Ophthalmic Drugs Market by Dispense Type 6.2.3. Europe Ophthalmic Drugs Market by Country 6.3. Asia-Pacific 6.3.1. Asia-Pacific Ophthalmic Drugs Market by Disease Condition 6.3.2. Asia-Pacific Ophthalmic Drugs Market by Dispense Type 6.3.3. Asia-Pacific Ophthalmic Drugs Market by Country 6.4. RoW 6.4.1. RoW Ophthalmic Drugs Market by Disease Condition 6.4.2. RoW Ophthalmic Drugs Market by Dispense Type 6.4.3. RoW Ophthalmic Drugs Market by Sub-region 7. Company Covered 7.1. Abbott Healthcare 7.2. Allergan Plc